The European Journal of Obstetrics & Gynecology and Reproductive Biology is the leading general clinical journal covering all European countries. It publishes peer reviewed original research articles, expert opinions and reviews, and also news, book reviews and biographical, historical and educational articles. Fields covered include obstetrics, prenatal diagnosis, materno-fetal medicine, perinatology, general gynecology, gynecologic oncology, uro-gynecology, reproductive medicine, infertility, reproductive endocrinology, sexual medicine and reproductive ethics. It provides a forum for scientific and clinical professional communication in obstetrics and gynecology throughout Europe and the world.
The following articles will be considered for publication: original research articles, review articles, expert opinions and letters to the Editor - brief communications (formerly case reports).
Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all Authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, without written consent of the Publisher.
Upon acceptance of an article, Authors will be asked to transfer copyright (for more information on copyright see http://www.elsevier.com/authors. This transfer will ensure the widest possible dissemination of information. A letter will be sent to the corresponding author confirming receipt of the manuscript. A form facilitating transfer of copyright will be provided.Articles must be written in English. Authors whose native language is not English are requested to have their manuscripts checked for linguistic correctness before submission.
English language help service
Upon request, Elsevier will direct authors to an agent who can check and improve the English of their paper (before submission). Please contact firstname.lastname@example.org for further information.
Submission to the European Journal of Obstetrics & Gynecology and Reproductive Biology (EJOG) proceeds totally online. Paper copies of submissions are no longer acceptable. Via the web submission system for this journal, http://ees.elsevier.com/euro you will be guided stepwise through the creation and uploading of the various files. You will need to provide an electronic version of your manuscript and a separate electronic version of the abstract. You must select a category for your manuscript (see below). Once the uploading is done, the system automatically generates an electronic (PDF) proof, which is then used for reviewing. All correspondence, including the Editor's decision and request for revisions, will be by e-mail.
An agreement by all authors (maximum 6 to 7) is required for submission. A statement to this effect is requested at submission stage.
This policy concerns the addition, deletion, or rearrangement of author names in the authorship of accepted manuscripts:
Before the accepted manuscript is published in an online issue: Requests to add or remove an author, or to rearrange the author names, must be sent to the Journal Manager from the corresponding author of the accepted manuscript and must include: (a) the reason the name should be added or removed, or the author names rearranged and (b) written confirmation (e-mail, fax, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. Requests that are not sent by the corresponding author will be forwarded by the Journal Manager to the corresponding author, who must follow the procedure as described above. Note that: (1) Journal Managers will inform the Specialty Editors of any such requests and (2) publication of the accepted manuscript in an online issue is suspended until authorship has been agreed.
After the accepted manuscript is published in an online issue: Any requests to add, delete, or rearrange author names in an article published in an online issue will follow the same policies as noted above and result in a corrigendum.
During submission the author must select a category from the following list: Review Article, Research Article, Book Review, Letter to the Editor. In preparing submissions, authors should check the general requirements for the preparation of manuscripts (see below)
As well as invited articles we welcome submitted reviews on topics of current interest in obstetrics and gynecology. Reviews are allowed a maximum of 3500 words (excluding title page, abstract and references), 10 figures and 10 tables. The reference list should not exceed 3 pages.
These are generally ″invited″ by the Editor-in-Chief but submission may be considered, with a maximum of 2000 words, 20 citations and 2 figures or 2 tables.
For details, see below: ″General Requirements for the preparation of manuscripts″. There is a limit of 2500 words (excluding title page, abstract and references), 10 figures and 10 tables. The reference list should not exceed 3 pages.
Letters to the Editor are limited to a maximum of 600 words (excluding references, names and addresses of the signers, and the phrase "to the Editor"). Only one type of letter will be considered for publication:
Letter to the Editor - Brief Communication giving a brief case presentation or short report of a pertinent clinical observation. Please use the correct format following the criteria: max 600 words, max 5 references, max 1 table or 1 figure, no abstract, no keywords, no headings. The information must be presented as a true Letter, e.g. starting with ″Dear Editor, we found that... etc.″ Brief communications that do not meet this criteria will be returned to the author.
Editorial review process
Authors are responsible for following the criteria for the manuscript categories listed above before submitting the article to the Editorial Office. Articles not meeting these criteria will be rejected immediately without going through to peer review.
- having sound methodological structure
- reporting novel results
- driving the field forward
- being within the scope of the journal
- being written clearly and understandably for a reviewer to do his/her job properly, and
- a potential for FastTrack review and publication
Articles not meeting these criteria will be rejected immediately without going through to full peer review.
Articles that have passed the initial review process are assigned by the Editorial Office to a Specialty Editor on the basis of the corresponding author's address. At least 2 independent reviewers are assigned per article for a systematic review of the article's aims, methodology, results and conclusions.Following peer review, articles may be accepted without revision, accepted pending minor revision, not accepted but eligible for re-submission following major revision, or rejected. No more than two revision cycles are permitted per article - articles that after two revisions have still not adequately addressed the reviewers and Specialty Editors concerns will be rejected.
Authors are advised that during the review process the reviewers and/or the Specialty Editor may request additional statistical and language review. These articles will be reviewed by respectively an independent Statistical Advisor and Language Editor to the journal, either of whom may subsequently request additional changes prior to final acceptance of the manuscript.Author's suggested reviewers
With their submitted manuscript, authors must provide the names and addresses of at least two reviewers for the consideration of the Editors in the Comments field during the online submission.
Human and non-human experimentation
The Editors require that manuscripts from a particular institution are submitted with the requisite authority (Ethical Committee). Reports of experiments on animals should state that the guidelines for the care and use of animals approved by the local institution were followed. For work described in your article involving human experimental investigations of any kind, must have been carried out in accordance with The Code of Ethics of the Declaration of Helsinki
The Editors of EJOG endorse and strongly encourage authors of reports of clinical trails to use the CONSORT checklist. The CONSORT E-Flowchart and a checklist of items to be included when reporting a cluster or randomised trial can both be found on CONSORT Checklist
Authors who believe there may be commercial interest in the their article, e.g. for advertising or reprints, are requested to provide brief notes on the reason why this might be the case, and indicate the company or types of company that might be interested in this service.
Each author (for manuscripts with 2 but not more than 6 to 7 authors) must qualify by having significantly participated in the study that is reported as well as made substantial contributions to the first concept and design or analysis and interpretation of data and second, writing the manuscript or revising it critically for content (see author agreement). Others contributing to the work should be recognised separately in an Acknowledgment.
General requirements for preparation of manuscripts
Manuscripts of research articles must be submitted in English and be structured in the following order on a new page: title page, condensation, abstract, body of text, acknowledgments, references, legends for figures and tables.
The title page should contain in sequence the title (concise and suitable for indexing purposes), author line with first name, middle initials, and last name of each author; city(ies), state(s) and countries in which the study was conducted; divisional, or departmental, and institutional affiliations at the time the study was performed; name, address, telephone number, fax number and e-mail address of author responsible for correspondence concerning the manuscript if different from author to whom reprint requests are addressed.
On the second page, provide a Condensation for use in the table of contents. This should be a single sentence of no more than 4 lines long, written in the present tense and stating in simple, declarative, and non-quantitative terms the conclusion(s) of the report.
On manuscript page 3, type the abstract, double-spaced, with the required margins and headed by the title or the article and name(s) of the author(s. Below the abstract list 3 to 5 key words or short phrases for indexing purposes. A structured abstract (see description) is required for original research articles. A standard abstract is required for review articles and expert opinions (see description).
Structured abstract: A structured abstract, limited to 350 words, should be used for research articles and should contain the following major headings:
Objective(s), Study Design, Results and Conclusion(s). The Objective(s) reflects the purpose of the study, that is, the hypothesis that is being tested. The Study Design should include the setting for the study, the subjects (number and type), the treatment or intervention, and the type of statistical analysis. The Results include the outcome of the study and statistical significance if appropriate. The Conclusion(s) state(s) the significance of the results.
A standard abstract is required for review articles and expert opinions and has no sub headings. It is limited to 500 words for reviews and 300 words for expert opinions.
Only standard abbreviations may be used. Consult the Council of Biology Editors Style Manual or the AMA's Manual of Style: http://healthlinks.washington.edu/hsl/styleguides/ama.html.
The generic, chemical or proprietary names of pharmaceuticals may be used. If the generic or chemical names are used, authors may, if they desire, insert the proprietary name in parentheses after the first mention in the text, with the name of the manufacturer and city and state.Research articles are customarily organised into the following sections: In the Introduction, state concisely the purpose and rationale for the study and cite only the most pertinent references as background. In the Materials and Methods section describe briefly the plan, the subjects, experimental animals or other species, material, and controls, the methods and procedures utilised, and the statistical method(s) employed. In the Results section present detailed findings. Include mentions of all tables, and/or figures. Figures and tables should supplement, not duplicate, the text; presentation of data in either one or the other will suffice. In the Comment section state the importance and significance of your findings. Limit your opinions to those strictly indicated by the facts in your report. Compare your findings with those of others. No new data should be presented in this section.
Acknowledge only persons, institutes and agencies who have made substantial contributions to the study.
Adhere to the maximum number of references for each category of article (see above). Number references consecutively in the order in which they are mentioned in the text. Use the format of the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals" (Vancouver style) (N Engl J Med 1991: 324: 424-8). Journal titles should conform to the abbreviations used in Cumulated Index Medicus. If six or fewer authors, list all; if seven or more authors, list three then "et al".
(1) Paterok EM, Roenthal H, Sabel M. Nipple discharge and abnormal galactogram. Results of a long-term study (1964-1999). Eur J Obstet Gynecol Reprod Biol 1993; 50: 227-34.
(2) Brown SS, ed. Prenatal Care. Reaching Mothers, reaching infants. Washington: National Academy Press, 1998.
Figures, Tables, Multi-media and Annexed files
Instructions on submitting these items online are provided under Artwork Instructions on the Journal's Instructions to Authors at http://www.elsevier.com/artworkinstructions.
Colour figures will be published in print for an additional charge to the author of USD 1250.00 per page. The quoted charge is per page in colour, and as many as eight colour figures can be included on one page if the colour balance is appropriate. The colours used must be dark enough and of sufficient contrast for reproduction. With the exception of fluorescent colours, all colours can be reproduced in four colour figures. Figures submitted in colour will be published in colour online without charge.Tables should be numbered in Arabic numerals. Each table must be cited in sequence at an appropriate point in the text. Titles should be brief yet indicate clearly the purpose or content of each table, and each column should be precisely defined by headings. Abbreviations and special designations should be explained in a footnote to the table. If a table or any part thereof has been taken from copyrighted material, a footnote to the table must give full credit to the original source.
Multi-media and annexed files are published only online. Multimedia files need to be sent to the Editorial Office on disk/cdrom or by e-mail, email@example.comVideo data
Elsevier accepts video material and animation sequences to support and enhance your scientific research. Authors who have video or animation files that they wish to submit with their article are strongly encouraged to include links to these within the body of the article. This can be done in the same way as a figure or table by referring to the video or animation content and noting in the body text where it should be placed. All submitted files should be properly labeled so that they directly relate to the video file's content. In order to ensure that your video or animation material is directly usable, please provide the files in one of our recommended file formats with a preferred maximum size of 50 MB. Video and animation files supplied will be published online in the electronic version of your article in Elsevier Web products, including ScienceDirect: http://www.sciencedirect.com. Please supply 'stills' with your files: you can choose any frame from the video or animation or make a separate image. These will be used instead of standard icons and will personalize the link to your video data. For more detailed instructions please visit our video instruction pages at http://www.elsevier.com/artworkinstructions. Note: since video and animation cannot be embedded in the print version of the journal, please provide text for both the electronic and the print version for the portions of the article that refer to this content.
The journal encourages authors to create an AudioSlides presentation with their published article. AudioSlides are brief, webinar-style presentations that are shown next to the online article on ScienceDirect. This gives authors the opportunity to summarize their research in their own words and to help readers understand what the paper is about. More information and examples are available at http://www.elsevier.com/audioslides. Authors of this journal will automatically receive an invitation e-mail to create an AudioSlides presentation after acceptance of their paper.
Photographs of identifiable persons must be accompanied by signed releases. If not, all recognisable features must be masked.
If excerpts from other copyrighted works are included (direct quotations, tables or figures) the Author(s) must obtain written permission from the copyright owners and credit source(s) in the article along with complete reference information. Elsevier has pre-printed forms for use by Authors in these cases: contact Elsevier's Rights Department, Philadelphia, PA, USA: phone (+1) 215 239 3804, fax (+1) 215 239 3805, e-mail firstname.lastname@example.org. Requests may also be completed online via the Elsevier homepage http://www.elsevier.com/locate/permissions.Conflict of interest
All authors must disclose any financial and personal relationships with other people or organisations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding.
Role of the funding source
All sources of funding should be declared as an acknowledgement at the end of the text. Authors should declare the role of study sponsors, if any, in the collection, analysis and interpretation of data and in the writing of the manuscript. If the study sponsors had no such involvement, the authors should so state.
One set of pdf proofs will be sent to the authors to be carefully checked for printer's errors. Changes or additions to the edited manuscript will not be allowed at the this stage. Authors are requested to return the corrected proofs immediately by fax or e-mail as instructed.
The corresponding author, at no cost, will be provided with a PDF file of the article via e-mail. The PDF file is a watermarked version of the published article and includes a cover sheet with the journal cover image and a disclaimer outlining the terms and conditions of use.
Additional paper offprints can be ordered by the authors. An order form with prices will be sent to the corresponding author. This must be completed and returned to the publisher with the proofs. Orders for reprints cannot be accepted at a later date because the reprints are made at the time the journal is printed.
Communications of a business nature should be addressed to: The Publisher, European Journal of Obstetrics & Gynecology and Reproductive Biology, Elsevier B.V., Health Sciences, PO Box 993, 1000 AZ Amsterdam, The Netherlands, Tel: (+31) 20 485 3007; Fax: (+31) 20 485 3249
The European Journal of Obstetrics & Gynecology and Reproductive Biology is cited in: Current Contents (Clinical Medicine), Index Medicus (MEDLINE), Excerpta Medica (EMBASE), Pascal et Francis (INIST-CNRS), Elsevier BIOBASE/Current Awareness in Biological Sciences.
The European Journal of Obstetrics & Gynecology and Reproductive Biology has no page charges.
Table of Contents and Abstracts of published articles are freely accessible at http://www.sciencedirect.com/science/journal/03012115.Funding body agreements and policies
Elsevier has established agreements and developed policies to allow authors whose articles appear in journals published by Elsevier, to comply with potential manuscript archiving requirements as specified as conditions of their grant awards. To learn more about existing agreements and policies please visit http://www.elsevier.com/fundingbodies
This journal offers authors two choices to publish their research:
• Articles are freely available to both subscribers and the wider public with permitted reuse
• An Open Access publication fee is payable by authors or their research funder
• Articles are made available to subscribers as well as developing countries and patient groups through our access programs (http://www.elsevier.com/access)
• No Open Access publication fee
All articles published Open Access will be immediately and permanently free for everyone to read and download. Permitted reuse is defined by your choice of one of the following Creative Commons user licenses:
Creative Commons Attribution-Non Commercial-ShareAlike (CC BY-NC-SA): for non-commercial purposes, lets others distribute and copy the article, to create extracts, abstracts and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text and data mine the article, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, do not modify the article in such a way as to damage the author's honor or reputation, and license their new adaptations or creations under identical terms (CC BY NC SA).
Creative Commons Attribution-NonCommercial-NoDerivs (CC-BY-NC-ND): for non-commercial purposes, lets others distribute and copy the article, and to include in a collective work (such as an anthology), as long as they credit the author(s) and provided they do not alter or modify the article.
Creative Commons Attribution (CC-BY): available only for authors funded by organizations with which we have established an agreement with. For a full list please see http://www.elsevier.com/fundingbodies
To provide Open Access, this journal has a publication fee which needs to be met by the authors or their research funders for each article published Open Access. Your publication choice will have no effect on the peer review process or acceptance of submitted articles.The Open Access publication fee for this journal is $USD 2500, excluding taxes.Learn more about Elsevier's pricing policy, http://www.elsevier.com/openaccesspricing